ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
672 |
219K |
9 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
672
|
219K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
|
|
ma420
|
104 |
31K |
2 |
16/05/24 |
16/05/24 |
ASX - By Stock
|
104
|
31K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor presentation, 15 May 2024
|
|
ma420
|
34 |
19K |
0 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
34
|
19K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor presentation, 15 May 2024
|
|
ma420
|
34 |
19K |
4 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
34
|
19K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor presentation, 15 May 2024
|
|
ma420
|
34 |
19K |
1 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
34
|
19K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor presentation, 15 May 2024
|
|
ma420
|
34 |
19K |
3 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
34
|
19K
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ma420
|
11K |
3.8M |
11 |
15/05/24 |
15/05/24 |
General
|
11K
|
3.8M
|
11
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ma420
|
11K |
3.8M |
20 |
15/05/24 |
15/05/24 |
General
|
11K
|
3.8M
|
20
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ma420
|
2.2K |
749K |
24 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
2.2K
|
749K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
|
|
ma420
|
104 |
31K |
8 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
104
|
31K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
|
|
ma420
|
104 |
31K |
7 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
104
|
31K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
|
|
ma420
|
104 |
31K |
11 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
104
|
31K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
|
|
ma420
|
104 |
31K |
1 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
104
|
31K
|
1
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
ma420
|
234 |
62K |
5 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
234
|
62K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
|
|
ma420
|
104 |
31K |
6 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
104
|
31K
|
6
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
672 |
219K |
8 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
672
|
219K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
|
|
ma420
|
104 |
31K |
5 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
104
|
31K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
|
|
ma420
|
104 |
31K |
19 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
104
|
31K
|
19
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
|
|
ma420
|
104 |
31K |
25 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
104
|
31K
|
25
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene with Decitabine Enhances Cancer Cell Killing
|
|
ma420
|
104 |
31K |
49 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
104
|
31K
|
49
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
227 |
97K |
3 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
227
|
97K
|
3
|
|
ASX - By Stock
|
CVB |
Re:
CVB Media Links
|
|
ma420
|
9 |
4.6K |
0 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
9
|
4.6K
|
0
|
|
ASX - By Stock
|
CVB |
Re:
CVB Media Links
|
|
ma420
|
9 |
4.6K |
0 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
9
|
4.6K
|
0
|
|
ASX - By Stock
|
CVB |
CVB - General discussions
|
|
ma420
|
1 |
568 |
0 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
1
|
568
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RAC Investor Presentation May 2024
|
|
ma420
|
55 |
15K |
5 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
55
|
15K
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ma420
|
21K |
7.4M |
8 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
21K
|
7.4M
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RAC Investor Presentation May 2024
|
|
ma420
|
55 |
15K |
10 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
55
|
15K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: RAC Investor Presentation May 2024
|
|
ma420
|
55 |
15K |
11 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
55
|
15K
|
11
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
672 |
219K |
3 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
672
|
219K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
ma420
|
234 |
62K |
9 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
234
|
62K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
ma420
|
234 |
62K |
5 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
234
|
62K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
ma420
|
234 |
62K |
9 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
234
|
62K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
ma420
|
234 |
62K |
5 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
234
|
62K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene
|
|
ma420
|
234 |
62K |
9 |
11/05/24 |
11/05/24 |
ASX - By Stock
|
234
|
62K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
ma420
|
250 |
64K |
8 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
250
|
64K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
ma420
|
250 |
64K |
5 |
10/05/24 |
10/05/24 |
ASX - By Stock
|
250
|
64K
|
5
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
227 |
97K |
14 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
227
|
97K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Board Changes
|
|
ma420
|
250 |
64K |
2 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
250
|
64K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
ma420
|
5 |
2.3K |
25 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
5
|
2.3K
|
25
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
227 |
97K |
8 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
227
|
97K
|
8
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
227 |
97K |
13 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
227
|
97K
|
13
|
|
ASX - By Stock
|
DXB Medicine |
Re:
DXB Media thread.
|
|
ma420
|
174 |
82K |
7 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
174
|
82K
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
Clarity Pharma has been featured in the latest Thematic Insights Report - Download now!
|
|
ma420
|
10 |
3.4K |
2 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
10
|
3.4K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Clarity Pharma has been featured in the latest Thematic Insights Report - Download now!
|
|
ma420
|
10 |
3.4K |
1 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
10
|
3.4K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
672 |
219K |
11 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
672
|
219K
|
11
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
ma420
|
672 |
219K |
11 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
672
|
219K
|
11
|
|
ASX - By Stock
|
LLL |
Re:
Ann: MoU Signed with Mali Gov & Sale of Entire Project to Ganfeng
|
|
ma420
|
762 |
256K |
3 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
762
|
256K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
227 |
97K |
12 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
227
|
97K
|
12
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
227 |
97K |
2 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
227
|
97K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
227 |
97K |
9 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
227
|
97K
|
9
|
|